| Drug Name |
Moexipril hydrochloride |
| Drug ID |
BADD_D01485 |
| Description |
Moexipril is a non-sulfhydryl containing precursor of the active angiotensin-converting enzyme (ACE) inhibitor moexiprilat. It is used to treat high blood pressure (hypertension). It works by relaxing blood vessels, causing them to widen. Lowering high blood pressure helps prevent strokes, heart attacks and kidney problems. |
| Indications and Usage |
For the treatment of hypertension. |
| Marketing Status |
approved |
| ATC Code |
C09AA13 |
| DrugBank ID |
DB00691
|
| KEGG ID |
D00623
|
| MeSH ID |
C058302
|
| PubChem ID |
54889
|
| TTD Drug ID |
D00HDU
|
| NDC Product Code |
68462-208; 17404-0018; 0093-0017; 0093-5150; 66039-838; 68462-209 |
| UNII |
Q1UMG3UH45
|
| Synonyms |
moexipril | 2-((1-ethoxycarbony)-3-phenylpropylamino-1-oxopropyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid | Fempress | moexipril hydrochloride | Univasc | Moex | Perdix | RS 10085 | RS-10085 |
